Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development.
about
Major histocompatibility complex class II inhibits fas antigen-mediated gastric mucosal cell apoptosis through actin-dependent inhibition of receptor aggregationDendritic cell density and activation status in human breast cancer -- CD1a, CMRF-44, CMRF-56 and CD-83 expression.Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities.CD169 mediates the capture of exosomes in spleen and lymph node.Dissociation of caspase-mediated events and programmed cell death induced via HLA-DR in follicular lymphoma.Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1α and lipopolysaccharide.
P2860
Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Differential susceptibility to ...... ne dendritic cell development.
@en
Differential susceptibility to CD95
@nl
type
label
Differential susceptibility to ...... ne dendritic cell development.
@en
Differential susceptibility to CD95
@nl
prefLabel
Differential susceptibility to ...... ne dendritic cell development.
@en
Differential susceptibility to CD95
@nl
P2093
P2860
P356
P1476
Differential susceptibility to ...... ne dendritic cell development.
@en
P2093
Bröcker EB
Leverkus M
McLellan AD
Mengling T
Starling GC
P2860
P2888
P304
P356
10.1038/SJ.CDD.4400734
P577
2000-10-01T00:00:00Z